according to the 2022 Quest Diagnostics Drug Testing Index (DTI). The rate of positive drug test results among America's total workforce reached its highest rate last year since 2001 and was up ...
The Quest Diagnostics white paper, "Rare Disease Diagnostics: Advancing Orphan Drug Development through Precision Testing", offers an in-depth analysis of the current state of rare disease ...
“Quest is a leader in cancer diagnostics and knows how to scale these innovations to make them broadly accessible to patients in need. With their support, we are positioned to advance commercial ...